Saccharomyces boulardii 250 mg Chewable Tablet
RxNorm 1301032

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1301032 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Saccharomyces boulardii 250 mg Chewable Tablet.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Saccharomyces boulardii 250 mg Chewable Tablet
Primary clinical definition
AUI:4626498
View
PSN
Saccharomyces boulardii 250 mg Chewable Tablet
AUI:6359678
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
Saccharomyces boulardii 250 mg Chewable Tablet
(Atom ID: 4626498)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Saccharomyces boulardii 250 MG Chewable Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1301032
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
4626498
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1301032
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{580284} 236782
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{580284} 236782
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{580284} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXTERM FORM
Tab
The RxTerm dose form name for this drug
PSNPrescribable

Prescribable Name (PSN):
Saccharomyces boulardii 250 mg Chewable Tablet
(Atom ID: 6359678)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Saccharomyces boulardii 250 MG Chewable Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1301032
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6359678
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1301032
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Saccharomyces Boulardii


What is it? Saccharomyces boulardii is a yeast believed to be a strain of Saccharomyces cerevisiae. It is likely effective for treating certain types of diarrhea.

Saccharomyces boulardii is called a "probiotic," a friendly organism that helps to fight off "bad" organisms that might cause diseases. Saccharomyces boulardii is different from other strains of Saccharomyces cerevisiae, commonly known as brewer's yeast and baker's yeast.

Saccharomyces boulardii is most commonly used for treating and preventing diarrhea, including rotaviral diarrhea in children. It has some evidence of use for other types of diarrhea, acne, and a digestive tract infection that can lead to ulcers. There is no good evidence to support using Saccharomyces boulardii for COVID-19.


[Learn More]


* Please review the disclaimer below.